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Although the Notch signaling pathway is one of the
most intensely studied intracellular signaling path-
ways, the mechanisms by which Notch signaling
regulates transcription remain incompletely under-
stood. Here, we report that B cell leukemia/lym-
phoma 6 (BCL6), a transcriptional repressor, is a
Notch-associated factor. BCL6 is necessary tomain-
tain the expression of Pitx2 in the left lateral plate
mesoderm during the patterning of left-right asym-
metry in Xenopus embryos. For this process, BCL6
forms a complex with BCL6 corepressor (BCoR)
on the promoters of selected Notch target genes
such as enhancer of split related 1. BCL6 also inhibits
the transcription of these genes by competing for the
Notch1 intracellular domain, preventing the coactiva-
tor Mastermind-like1 (MAM1) from binding. These
results define a mechanism restricting Notch-acti-
vated transcription to cell-type-appropriate subsets
of target genes, and elucidate its relevance in vivo
during left-right asymmetric development.
INTRODUCTION
Vertebrates show conserved anatomical left-right (LR) asymme-
try of the internal organs such as the orientation of the cardiovas-
cular system, visceral organs, and the number of lung lobes,
whereas their external bodies are bilaterally symmetrical (Levin,
2005; Palmer, 2004). Althoughmany of themechanisms involved
in breaking LR symmetry during early development may not be
conserved, the universal hallmark of vertebrate LR asymmetric
development is left-side-specific expression of genes such as
Nodal, Lefty, and Pitx2 in the lateral plate mesoderm (LPM)
(Boorman and Shimeld, 2002; Raya andBelmonte, 2006; Speder
et al., 2007). Indeed, these genes play crucial roles during the
patterning of LR asymmetry (Capdevila et al., 2000; Hamada
et al., 2002).
The Notch signaling pathway is a well conserved signaling
pathway in animals (Borggrefe and Oswald, 2009). After an inter-
action between the Delta/Serrate/Lag-2 (DSL) ligand and the
Notch receptor, the Notch receptor intracellular domain (NICD)
is released from the membrane by two sequential proteolytic450 Developmental Cell 18, 450–462, March 16, 2010 ª2010 Elseviercleavages. NICD subsequently translocates into the nucleus
and forms a complex with nuclear proteins, including the
C-promoter-binding factor 1/Suppressor of Hairless/Lag-1
(CSL) transcriptional factor and the transcriptional coactivator,
Mastermind-like (MAM), to activate the transcription of target
genes. Notch signaling has been demonstrated to affect LR
asymmetry in mice (Krebs et al., 2003; Raya et al., 2003), chick
(Raya et al., 2004), and zebrafish (Kawakami et al., 2005; Raya
et al., 2003). Previous studies in mice demonstrated that Notch
signaling directly regulates early symmetric expression of Nodal
through a node-specific enhancer (Adachi et al., 1999; Brennan
et al., 2002; Norris and Robertson, 1999), which contains two
functional binding sites for CSL (Krebs et al., 2003; Raya et al.,
2003). Interestingly, although the expression of Pitx2 in the left
LPM is initiated by Nodal (Shiratori et al., 2001), it can also be
induced by downregulation of Notch signaling even in the
absence of Nodal function (Krebs et al., 2003; Raya et al.,
2003), suggesting that the expression of Pitx2 is regulated by
both Nodal-dependent and -independentmechanisms. Thus far,
the regulatory mechanism governing Pitx2 expression remains
incompletely understood.
B cell leukemia/lymphoma 6 (BCL6) is a sequence-specific
transcriptional repressor that recruits a wide variety of corepres-
sors, including BCL6 corepressor (BCoR) (Huynh et al., 2000).
BCL6 was originally identified via chromosomal translocations
affecting band 3q27, which are common in B cell non-Hodgkin
lymphoma (Baron et al., 1993; Kerckaert et al., 1993; Ye et al.,
1993). In fact, deregulated BCL6 expression is commonly
observed in diffuse large B cell lymphomas and follicular
lymphomas (Ohno, 2004; Pasqualucci et al., 2003). During
normal B cell development, BCL6 is required for the formation
of germinal centers (GC) (Dent et al., 1997; Ye et al., 1997) and
maintains the expression of GC-specific genes by suppressing
genes involved in B cell activation in response to DNA damage,
cell cycle regulation, and plasma cell differentiation (Li et al.,
2005; Niu et al., 2003; Phan and Dalla-Favera, 2004; Ranuncolo
et al., 2007; Shaffer et al., 2001; Tunyaplin et al., 2004; Vasan-
wala et al., 2002). Whereas the function of BCL6 in the formation
of lymphoma and normal B cell development has been well
studied, its roles during embryogenesis are poorly understood.
Here, we report that BCL6 is a transcriptional repressor asso-
ciated with Notch signaling during Xenopus LR patterning. By
binding NICD, preventing MAM1 recruitment, and associating
instead with BCoR, BCL6 inhibits certain Notch-induced target
genes such as enhancer of split related 1 (ESR1). Target gene
specificity is achieved by direct binding of BCL6 to relevantInc.
Figure 1. BCL6 Interacts with the ANK
Domain of Notch1
(A) Lane 1, GST/embryonic protein extract; lane 2,
GST-ANK; and lane 3, GST-ANK/embryonic pro-
tein extract. a, BCL6; c, b-actin. GST-ANK is indi-
cated by an asterisk.
(B) Protein extracts from stage-25 embryos were
incubated with a-Notch1 or a-BCL6 antibody.
Mouse IgGwas used for amock immunoprecipita-
tion.
(C) GST-BCL6 constructs. The numbers on the top
indicate the positions of amino acids.
(D) The top panel shows the expression of GST
constructs, and the bottom panel shows the inter-
actions between Flag-tagged NICD (Flag-NICD)
and GST-BCL6 constructs. Each arrowhead indi-
cates an intact GST fusion protein.
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of Pitx2 and thus LR asymmetry. Our studies elucidate crosstalk
between Notch signaling and the BCL6/BCoR complex, and
further show that BCL6 functions as a repressor of Notch
signaling during LR patterning.
RESULTS
Isolation of Notch-Associated Proteins
In studies to understand howNotch signaling regulates transcrip-
tion during embryogenesis, we sought novel transcriptional
regulators that can interact with NICD. A GST fusion protein
containing the ankyrin-like repeats domain of NICD protein
(GST-ANK) was used to isolate interacting proteins by immuno-
precipitation. The ANK domain was utilized because it is an
important domain required for the transcriptional activation of
Notch signaling and for interaction with the CSL transcriptional
factor (Kato et al., 1997), MAM (Kurooka et al., 1998), the histone
acetyltransferase complex (Tani et al., 2001), and Deltex (Dieder-
ich et al., 1994; Matsuno et al., 1995). Precipitation was per-
formed with GST-ANK and protein extracts from 100 embryos
at stages 15, 20, and 25. The coprecipitated proteins were sepa-
rated by one-dimensional (1D) gel electrophoresis, followed by
silver staining (Figure 1A). Three bands in lane 3 (GST-ANK +
protein extract) were specific when compared with lane 1
(GST + protein extract), which shows GST-associated bacterial
and embryonic proteins, and lane 2 (GST-ANK alone), which
shows GST-ANK-associated bacterial proteins. Via mass spec-
trometry analysis, we identified one of these bands, indicated
by ‘‘a’’ in Figure 1A, as BCL6. Deltex1, which is a regulator of
Notch signaling (Diederich et al., 1994; Matsuno et al., 1995,
1998), was also identified from the same protein band, although
the MASCOT score was not high (data not shown). To determine
if BCL6 endogenously interacts with Notch1, we performed
coimmunoprecipitation studies with a-Notch antibody, whichDevelopmental Cell 18, 450–46recognizes the intracellular domain of
Notch1, or a-BCL6 antibody. Using pro-
tein extracts from Xenopus embryos,
a specific endogenous association
betweenNotch1 andBCL6was observed
(Figure 1B). In addition, Suppressor ofHairless (Su(H)), a Xenopus ortholog of CSL, was also coprecipi-
tated by a-BCL6 antibody (Figure 1B).
To delineate the domain of BCL6 responsible for the interac-
tion with Notch1, binding assays were performed. As the known
functional domains of BCL6 are the POZ/BTB domain (POZ) at
the N terminus, the repression domain II (RDII) in the middle,
and the C2H2-type zinc finger (ZF) domain at the C terminus
(Albagli-Curiel, 2003; Chang et al., 1996), eight GST-BCL6 fusion
constructs harboring the individual domains were generated
(Figure 1C). Immunoprecipitation studies between in vitro-trans-
lated Flag-tagged NICD protein and purified GST-fused BCL6
fragments were performed. The Notch-binding domain of
BCL6 was localized to the region of BCL6 that harbored the
RDII region (M2 in Figure 1C) and the M3 region (Figure 1D).
These regions also interacted with the ANK domain alone (see
Figure S1A available online). In addition, interaction studies
with in vitro-translated proteins demonstrate that BCL6 appears
to directly interact with NICD, but not Su(H) (Figure S1B).
BCL6 Is Required for the Patterning of the LR Axis
in Xenopus
To determine functional roles for BCL6 in Notch signaling, the
role of BCL6 during embryogenesis was first examined. BCL6
was expressed in ectodermal and mesodermal tissues through
early embryogenesis (Figures S2A and S2B). The injection of
the highest dose (2 ng) of BCL6 RNA into one blastomere of
2-cell-stage embryos or a single dorsal or ventral blastomere
of 4-cell-stage embryos did not elicit anymorphological changes
in the injected embryos (data not shown). We employed a Mor-
pholino Antisense Oligo (MO) against BCL6 (BCL6 MO), which
binds sequences encompassing the ATG site of directed tran-
scripts and inhibits protein translation, thus depleting the endog-
enous protein (Heasman et al., 2000). The injection of BCL6 MO
significantly reduced endogenous BCL6 protein (Figure S2C).
BCL6 MO or a control MO (Control MO), which targets human2, March 16, 2010 ª2010 Elsevier Inc. 451
Figure 2. Related Functions of BCL6 and Notch Signaling during LR
Patterning
(A) 40 ng BCL6 MO, 40 ng Control MO, or/and 2 ng mBCL6-GR was injected
for each experiment. An arrow or a spiral indicates the orientation of the heart
or the gut coiling, respectively. Ventral views are shown.
(B) The normal left-specific expression of Xnr1 or Pitx2 is indicated by an arrow
in the nucb-gal-injected embryo.
(C) 80 ng Notch1 MO or 80 ng Control MO was injected for each experiment.
An arrow or a spiral indicates the orientation of the heart or the gut coiling,
respectively. Ventral views are shown.
(D and E) 150 ng Notch1 MO, 150 ng Control MO, or/and 1 ng GR-NICD RNA
was injected for each experiment. The dotted line indicates the embryonic
midline. The injected side is indicated by ‘‘L’’ (left) or ‘‘R’’ (right) beside the
names of the injected samples. L, left; R, right; a, anterior; p, posterior.
Developmental Cell
BCL6 Blocks Select Notch-Dependent Transcriptionbeta-globin pre-mRNA and does not recognize BCL6 mRNA,
was injected into a dorsal blastomere of 4-cell-stage embryos.
Green fluorescent protein (GFP) RNA was coinjected as a tracer
(data not shown). When 40 ng BCL6 MO was injected into a left
dorsal blastomere of 4-cell-stage embryos, striking abnormali-
ties in the orientation of gut origin, gut coiling, and the heart
were observed (Figure 2A; Table 1). The gut origin occurred at
the left (27.8%, n = 115) and gut coiling was clockwise (34%,
n = 115), whereas the normal gut origin occurs at the right and452 Developmental Cell 18, 450–462, March 16, 2010 ª2010 Elseviernormal gut coiling is counterclockwise. The orientation of the
heart was also inverted in a number of these BCL6 MO-injected
embryos (24.4%, n = 115). Phenotypes were scored according
to Branford et al. (2000). In contrast, there is no significant effect
in the Control MO-injected or right-side BCL6 MO-injected
embryos. In addition, the defects of gut extension were observed
in30% of the BCL6 MO-injected embryos, and these embryos
were not included when phenotypes were scored (data not
shown). To show the specificity of the BCL6 MO effect, we
coinjected BCL6 MO and a hormone-inducible mutant BCL6
(mBCL6-GR) RNA, whose translation initiation site was replaced
by the Myc tag and which is no longer recognized by BCL6 MO,
and examined gut and heart phenotypes. Except where noted
otherwise, we consistently added dexamethasone (DEX) to the
medium at stage 20, to activate a GR-fused protein. Thus acti-
vated, mBCL6-GR rescued gut origin (27.8% to 4.3%), gut coil-
ing (34% to 7.5%), and the heart (24.4% to 3.3%) phenotypes to
normal (Figure 2A; Table 1). As the failure of LR asymmetric
patterning causes the disorientation of gut origin, gut coiling,
and the heart (Branford et al., 2000), these results suggest that
the expression of BCL6 in the left side of embryos is necessary
for LR patterning.
To further study the role of BCL6 in the patterning of LR asym-
metry, we first characterized the role of BCL6 in the conserved
Nodal-Pitx2 cascade that governs LR patterning. The expression
of left-side-specific genes,Xnr1 (a Nodal paralog) andPitx2 (Lohr
et al., 1997; Ohi andWright, 2007; Schweickert et al., 2000; Von-
ica and Brivanlou, 2007), were tested in the BCL6-depleted
embryos. BCL6 MO or Control MO was injected into a left dorsal
blastomere of 4-cell-stage embryos, and the expression of Xnr1
at stage 22 and Pitx2 at stage 25 in the left LPM was examined.
Interestingly, the injection of BCL6 MO suppressed the expres-
sion of Pitx2 (100%, n = 28), but not Xnr1 (0%, n = 28) (Fig-
ure 2B; see RT-PCR in Figures S2D and S2E). Aswith the general
embryonic LR defects, these gene expression patternswere also
rescued by coinjection of mBCL6-GR (0% to 97%) (Figure 2B).
Although we were unable to detect BCL6 in the left LPM at stage
25 by whole-mount in situ hybridization (Figure S2A), RT-PCR
clearly revealed LR symmetric BCL6 expression in the LPM at
this stage (Figure S2F). Thus, BCL6 is required for the expression
of Pitx2, but not Xnr1, in the left LPM.
Dual Roles of Notch Signaling during LR Patterning
Are Conserved in Xenopus
Previous studies in mice showed that Notch signaling initiates
the symmetric expression of Nodal perinodally, whereas the
downregulation of Notch signaling acts independently of Nodal
at later stages, to allow the expression of Pitx2 in the LPM (Krebs
et al., 2003; Raya et al., 2003). This suggests that Notch signaling
is involved in the regulation of bothNodal andPitx2 expression at
different developmental stages. In particular, Notch activity at
the later stage, which could suppress the expression of Pitx2,
may be a possible target of BCL6 during LR patterning. We
therefore sought to confirm that Notch signaling has a conserved
function in these aspects of LR patterning in Xenopus.
At stage 18, Xenopus Notch1 and Notch ligands, Delta1 and
Serrate1, were expressed on the gastrocoel roof plate (GRP),
which is analogous to the amniote node (Schweickert et al.,
2007) (Figure S2G); this is where the expression of Xnr1 isInc.
Table 1. Laterality Scoring in BCL6 MO, NBD-S, or Notch1 MO Injection
Injection Injection Side
Cardiac Orientation, Forward Cardiac Orientation, Reverse
n
Gut Origin Right Gut Origin Left Gut Origin Right Gut Origin Left
CCWa CWb CCW CW CCW CW CCW CW
Uninjected 95.4 2.3 0.8 1.5 0.0 0.0 0.0 0.0 130
BCL6 MO
40 ng Control MO Left 96.1 1.3 2.6 0.0 0.0 0.0 0.0 0.0 76
20 ng Control MO Left 97.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 89
40 ng BCL6 MO Right 90.5 1.9 1.9 1.0 1.0 0.0 1.9 1.9 105
20 ng BCL6 MO Right 90.7 1.9 3.7 0.9 0.9 0.0 0.9 0.9 108
40 ng BCL6 MO Left 47.0 11.3 7.8 9.6 7.0 7.0 4.3 6.1 115
20 ng BCL6 MO Left 59.5 20.2 6.0 9.5 1.2 2.4 0.0 1.2 84
40 ng BCL6 MO/2 ng mBCL6-GR Left 89.4 4.3 1.1 2.1 1.1 1.1 1.1 0.0 94
20 ng BCL6 MO/2 ng mBCL6-GR Left 85.7 3.1 2.0 1.0 1.0 2.0 2.0 3.1 98
NBD-S
1 ng NBD-S-GR Left 70.0 7.0 6.0 3.0 5.0 2.0 4.0 3.0 100
2 ng NBD-S-GR Left 55.0 11.0 9.0 4.0 4.0 3.0 8.0 4.0 98
Notch1 MO
150 ng Control MO Left 83.7 2.4 8.1 2.4 0.8 0.8 0.8 0.8 123
80 ng Control MO Left 91.3 3.6 2.2 2.9 0.0 0.0 0.0 0.0 138
150 ng Notch1 MO Left 38.7 33.1 8.9 6.5 2.4 4.0 3.2 3.2 124
80 ng Notch1 MO Left 57.1 22.7 4.2 1.7 3.4 3.4 4.2 3.4 119
Lateral scoring is according to Branford et al. (2000). Numbers indicate the percentage of embryos displaying the phenotype (total embryos as n).
aCCW, counterclockwise.
bCW, clockwise.
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acquisition of LR asymmetry. Notch1 and Serrate1were also
expressed in the LPM at stage 25, similar to BCL6 (Figure S2F),
but Delta1 was hardly detected by RT-PCR (data not shown).
The injection of Notch1 MO significantly reduced endogenous
Notch1 protein (Figure S2C) and the expression of Notch target
genes (Figure S2H). When 80 ng Notch1 MO or Control MO was
injected into a left dorsal blastomere of 4-cell-stage embryos,
the orientation of gut origin (13.5%, n = 119), gut coiling
(31.2%, n = 119), and heart looping (14.4%, n = 119) was often
inverted (Figure 2C; Table 1). And, again, as seen in the BCL6
MO experiments, defects in gut extension were observed in
25% of the Notch1 MO-injected embryos, and these embryos
were not included when phenotypes were scored (data not
shown). Unlike BCL6 MO, however, the Notch1 MO suppressed
the expression of Xnr1 on both sides of the GRP at stage 18 (left:
93%, n = 30; right: 89%, n = 28) (Figure 2D; Figure S2I) and in the
left LPM at stage 22 (100%, n = 30) (Figure 2D). Although Xnr1
expression in theGRPwas not decreased in all cases, its expres-
sion completely disappeared from the LPM at stage 22. The
effects of the Notch1 MO were rescued by a hormone-inducible
NICD (GR-NICD) RNA. When GR-NICD was activated by DEX at
stage 12, Xnr1 expression in the GRP at stage 18 (left: 7% to
92%; right: 11% to 86%) and the left LPM at stage 22 (0% to
60%) was restored to normal levels (Figure 2D; Figure S2I).
These data indicate that Xenopus Notch signaling promotes
the expression of Xnr1 in the GRP during LR patterning.
The expression of Pitx2 in the Notch1 MO-injected embryos
was next examined. As Xnr1 expression in the stage-22 LPMDevelowas not observed in the Notch1 MO-injected embryos and the
expression of Pitx2 is initiated by Xnr1 (Ohi and Wright, 2007),
we predicted that Pitx2 expression would be completely abol-
ished in the Notch1 MO-injected embryos. However, Pitx2
expression was affected in only some of these embryos (65%,
n = 31) (Figure 2E). Interestingly, when Notch1MO andGR-NICD
RNA were coinjected for the rescue study, the expression of
Pitx2 was not rescued, and the number of embryos with sup-
pressed Pitx2 increased (65% to 100%, data not shown).
Accordingly, LR asymmetry defects induced by Notch1 MO
were not rescued by coinjection of GR-NICD (data not shown).
These findings suggest that, as in mice (Krebs et al., 2003;
Raya et al., 2003), the expression of Xenopus Pitx2 could occur
when Notch signaling was downregulated in the absence of Xnr1
function, and Notch signaling could suppress the expression of
Pitx2. We therefore decided to test this hypothesis inmore detail.
Indeed, when GR-NICD RNA was injected into a left dorsal
blastomere of 4-cell-stage embryos andGR-NICDwas activated
by DEX treatment at stage 20, Pitx2 expression was suppressed
(90%, n = 30) (Figure 3A). However, even when GR-NICD was
activated at stage 12, the expression of Xnr1 remained
unchanged (Figure 3A). Although an increase in Xnr1 expression
might have been expected, this result is consistent with the fact
that overexpression of GR-NICD on the right side rarely induced
the expression of Xnr1 (6%, n = 32) or Pitx2 (0%, n = 31) on the
injected side (data not shown). It is unclear why NICD is insuffi-
cient to induce Xnr1 or Pitx2 in Xenopus, but is sufficient to
do so in zebrafish (Raya et al., 2003); however, it is easy to
imagine that other factors required for Xnr1 expression are notpmental Cell 18, 450–462, March 16, 2010 ª2010 Elsevier Inc. 453
Figure 3. BCL6 Maintains Pitx2 Expression
by Inhibiting Notch Signaling
(A–D) 50 pgGR-NICD, 100 pgGR-at-Su(H), 100 pg
MAM1-GR, 2 ng GR-dn-Su(H), 2 ng dn-MAM1-
GR, or/and 2 ng mBCL6-GR was injected for
each experiment.
(E and F) The expression of Pitx2 at stage 25 was
tested by whole-mount in situ hybridization, and
the ratios of the Pitx2-expressing embryo number
versus the total tested embryo number are shown.
The total numbers of each injection are shown as
‘‘n’’ on the top of each bar.
(G) 2 ng NBD-S-GR or/and mBCL6-GR was
injected for each experiment. The injected side is
indicated by ‘‘L’’ (left) beside the names of the
injected samples. L, left; R, right; a, anterior; p,
posterior.
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versely, that NICD overexpression in zebrafish may only exert
early effects (on Nodal paralog expression), but may not last
long enough to inhibit Pitx2. In any case, taken together, these
findings suggest the possibility that BCL6 selectively antago-
nizes Notch-mediated inhibition of Pitx2 expression in Xenopus,
and that this antagonism forms the basis for BCL6 requirements
during LR asymmetric development.
BCL6 Inhibits Notch and Maintains Pitx2 Expression
by Interfering with MAM1
To test the possibility that BCL6 is necessary to suppress Notch
activity and maintain Pitx2 expression, GR-NICD and mBCL6-
GR RNA were coinjected into a left dorsal blastomere of 4-cell-
stage embryos, and the expression of Pitx2 was tested. BCL6
restored the expression of Pitx2 to normal levels (10% to 58%)
(Figure 3A), indicating that Notch signaling is indeed a likely
target of BCL6 during LR patterning.
We next examined whether the suppression of Pitx2 by Notch
signaling is mediated by Su(H) or MAM1. A hormone-inducible
active type of Su(H) fused to the VP16 activator domain (GR-
at-Su(H)) (Rones et al., 2000), or a hormone-inducible MAM1
(MAM1-GR) RNA, was injected into a left dorsal blastomere of454 Developmental Cell 18, 450–462, March 16, 2010 ª2010 Elsevier Inc.4-cell-stage embryos, and the expression
of Pitx2 was examined. Both at-Su(H)
(90%, n = 31) and MAM1 (91%, n = 32)
suppressed the expression of Pitx2
(Figures 3B and 3C). To test whether the
suppression of Pitx2 by Su(H) or MAM1
is inhibited by BCL6, GR-at-Su(H) or
MAM1-GR RNA was coinjected with
mBCL6-GR. BCL6 rescued MAM1
effects on Pitx2 (9% to 61%) (Fig-
ure 3C), but not at-Su(H) effects on Pitx2
(10% to 13%) (Figure 3B), suggesting
that BCL6 may interfere with specific
aspects of transcriptional activation by
the NICD/Su(H) complex. As at-Su(H)
can activate transcription of Notch target
genes without NICD, this result further
suggests that BCL6 does not competewith Su(H) to bind to the CSL-binding sites in the promoters of
target genes. To confirm the idea that BCL6’s principal function
in this context is to block Notch-dependent transcription, we
used a hormone-inducible dominant-negative form of Su(H)
(GR-dn-Su(H)), which has a mutation in the DNA-binding domain
and can still interact with NICD (Rones et al., 2000; Wettstein
et al., 1997), and a hormone-inducible dominant-negative form
of MAM1 (dn-MAM1-GR), which has only the Notch-binding
domain (Kiyota and Kinoshita, 2002). Coinjection of GR-dn-
Su(H) or dn-MAM1-GR RNA with BCL6 MO restored Pitx2
expression to normal levels (8% to 75% with GR-dn-Su(H),
n = 24; 8% to 84% with dn-MAM1-GR, n = 25) (Figure 3D), indi-
cating that blocking transcriptional outputs of Notch signaling
can rescue BCL6 MO phenotypes.
To further confirm endogenous crosstalk between Notch
signaling and BCL6, the following studies were performed. The
maximum amounts of GR-NICD RNA (10 pg) and BCL6 MO
(5 ng), which alone cannot sufficiently suppress the expression
of Pitx2, showed a synthetic interaction, suppressing Pitx2 (Fig-
ure 3E) and suggesting that endogenous BCL6 inhibits Notch
activity. Moreover, the Notch1 MO was epistatic to the BCL6
MO (Figure 3F), indicating that Notch signaling is an in vivo target
of BCL6 for the expression of Pitx2 (Figure S3A).
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Notch interactions, without affecting other BCL6 or Notch func-
tions, a hormone-inducible mutant BCL6 construct (NBD-S-GR),
which contains only the M3 domain, was generated (Figure 1C).
To our knowledge, the M3 domain has not been reported to be
required for the interaction between BCL6 and any other factors
thus far, yet we find it is sufficient to interfere with the interaction
between Notch1 and BCL6, while leaving the NICD transcrip-
tional complex (Figure S3B) and Notch activity (Figures S3C
and S3D) intact.NBD-S-GR RNAwas injected into the left dorsal
blastomere of 4-cell-stage embryos, and the expression of Pitx2
was examined. The expression of Pitx2 was inhibited by NBD-S
(87%, n = 31), and this inhibition was rescued by the coinjection
of mBCL6-GR RNA (13% to 76%) (Figure 3G). Note that the
defects of LR asymmetry were also observed in the NBD-S-
injected embryos (Table 1). To verify whether NBD-S enhances
the ability of Notch to suppress Pitx2, the maximum amounts
ofGR-NICD (10 pg) andNBD-S-GR (100 pg), which alone cannot
sufficiently suppress the expression of Pitx2, were coinjected,
and, again, a synthetic interaction was observed (Figure S3E).
These findings together support the proposal that BCL6 main-
tains LR asymmetry by rendering Pitx2 expression resistant to
the effects of Notch signaling.
In order to determine the molecular mechanism of this BCL6
effect, we sought BCL6-dependent changes in the composition
of Notch transcriptional complexes. BCL6 was overexpressed in
embryos, and coimmunoprecipitation with a-Notch1 antibody
was performed. MAM1, but not Su(H), was replaced by the over-
expressed BCL6 protein (Figure 4A). Interaction studies with
in vitro-translated proteins demonstrate that this interference
by BCL6 was dose dependent (Figure 4B). Conversely, the over-
expression of MAM1 and dn-MAM1 displaced BCL6 from the
transcriptional complex of Notch signaling (lanes 2 and 4 in Fig-
ure 4C). Note that NBD-S and MAM1 (Figure S3B) or dn-MAM1
(Figure 4D) did not exclude each other from the transcriptional
complex. It is possible that the NBD-S-binding site in the ANK
domain of NICD may not overlap with the MAM1-binding site
or/and NBD-S may interact with NICD more strongly than full-
length BCL6 because the truncation of other domains may
lead to conformation change. These data together demonstrate
that BCL6 competes with MAM1 for the ANK domain of NICD to
inhibit the transcriptional activity of Notch.
BCL6 Forms a Complex with BCoR
As a previous study in Xenopus showed that BCoR is required for
the expression of Pitx2 and LR patterning (Hilton et al., 2007) and
BCoR was expressed in the LPM at stage 25 (Figure 2C), we
examined whether BCoR is present in the Notch/BCL6 complex.
When immunoprecipitation with a-Notch1 antibody was per-
formed, BCoR was precipitated with the Notch/BCL6 complex
(Figure 4E). When BCL6 was knocked down by BCL6 MO, the
amount of BCoR precipitated by a-Notch1 antibody was
reduced (Figure 4F), suggesting that BCL6 recruits BCoR into
the transcriptional complex of Notch signaling. To examine
whether BCoR is functionally involved in the suppression of
Notch signaling, the enhancement of BCL6 effect by BCoR in
Pitx2 expression was tested. The number of Pitx2-expressing
embryos in the coinjection of GR-NICD and mBCL6-GR was
increased by the coinjection of BCoR (lanes 3 and 5 in Fig-Develoure 4G). Indeed, the overexpression of BCoR itself was sufficient
to attenuate NICD’s effects onPitx2 (lane 4 in Figure 4G), and this
BCoR activity was dependent on endogenous BCL6 (lane 6 in
Figure 4G). Collectively, our data indicate that BCL6 inhibits
Notch-dependent transcription by blocking NICD/Su(H) interac-
tions with the coactivator MAM1 and recruiting the corepressor
BCoR instead.
ESR1 Is a Notch Target Gene Suppressed by BCL6
during LR Patterning
In an effort to refine our model for BCL6 action, we looked for
direct target genes shared by BCL6 and Notch, where we might
test the mechanistic model discussed above. The expression of
Notch-activated genes in the LPM was therefore examined by
RT-PCR. Interestingly, the expression of ESR1 (Lamar and Kint-
ner, 2005; Wettstein et al., 1997) was barely detected, whereas
Hairy2 (Davis et al., 2001) was expressed (Figure S4A). To test
whether BCL6 differentially regulates the transcription of
selected Notch target genes, the expression of ESR1 and Hairy2
in the BCL6-depleted left LPM was tested by quantitative
RT-PCR. The expression of ESR1, but not Hairy2, was increased
in the BCL6-depleted LPM (Figure 5A) and in the nervous system
at stage 14 (Figure 5B). This increase of ESR1 expression by
BCL6 MO was decreased by the coinjection of Notch1 MO,
suggesting that BCL6 directly regulates the transcriptional
output of Notch signaling on ESR1 (Figure 5C). In addition, an
increase of ESR1 expression by NICD in the left LPM was
reduced by the coinjection of BCL6 (Figure S4B).
Next, the possibility that ESR1 mediates Notch signaling to
suppress the expression of Pitx2 was examined. A hormone-
inducible ESR1 (ESR1-GR) or Hairy2 (Hairy2-GR) RNA was
injected into a left dorsal blastomere of 4-cell-stage embryos,
and the expression of Pitx2 was tested. ESR1 (74%, n = 34),
but not Hairy2 (4%, n = 28), suppressed Pitx2 expression (Fig-
ure 5D; Figure S4C). To examine whether ESR1 is the primary
mediator of Notch effects on Pitx2, ESR1 was knocked down
with an MO (ESR1 MO) (Figure S4D). However, the ESR1 MO
was not able to rescue Pitx2 expression in BCL6 MO coinjected
embryos, indicating that other Notch target genes that converge
on Pitx2 are also suppressed by BCL6 in the left LPM (Figure 5E;
Figure S4E).
Chromatin immunoprecipitation (ChIP) assays with nuclear
extracts isolated from stage-25 embryos confirmed that Notch1
is associated with the known CSL-binding sites at the ESR1 and
Hairy2 genomic loci; however, BCL6 bound only the ESR1 CSL-
binding element (Figure 6A). We next examined whether BCL6
recruitment is dependent on the NICD. dn-Su(H) was used for
this study, because overexpressed dn-Su(H) dominantly inter-
acts with NICD but cannot bind the CSL-binding site (Wettstein
et al., 1997). dn-Su(H) overexpression prevented both Notch1
(lanes 7 and 8 in Figure 6B) and BCL6 (lanes 5 and 6 in
Figure 6B) from binding the ESR1 CSL-binding site. However,
BCL6 MO increases MAM1 occupancy of ESR1 CSL-binding
site (lanes 5 and 6 in Figure 6C) without affecting NICD (lanes 7
and 8 in Figure 6C). These data strongly suggest that BCL6
binds to the transcriptional complex present at the CSL-binding
site of ESR1 through NICD and competes with MAM1. However,
it still remains possible that BCL6 interacts directly with the ESR1
gene, at elements other than the CSL-binding site tested above.pmental Cell 18, 450–462, March 16, 2010 ª2010 Elsevier Inc. 455
Figure 4. The Mechanisms by Which the BCL6/BCoR Complex Blocks Notch-Dependent Transcription
(A) HA-tagged Su(H), Flag-tagged MAM1, or/and BCL6 was expressed in embryos, and protein extracts were isolated from 50 embryos at stage 10. Coimmu-
noprecipitation with a-Notch antibody was performed.
(B) Coimmunoprecipitation with in vitro-synthesized proteins.
(C and D) Flag-tagged MAM1, Flag-tagged dn-MAM1, BCL6, or/and Myc-tagged NBD-S was expressed in embryos, and protein extracts were isolated from
50 embryos at stage 10 for each experiment.
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Figure 5. ESR1 Is a Target of BCL6 during
LR Patterning and Neural Development
(A) BCL6 MO was injected into the left side of
embryos, and left LPM tissues were dissected
from 20 embryos at stage 25 for quantitative
RT-PCR. The injection side was traced by the
coinjection of GFP (data not shown). *p < 0.05,
n = 3.
(B) BCL6 MO was injected into a dorsal blasto-
mere of four-cell-stage embryos, and embryos
were fixed at stage 14. Increased ESR1 expres-
sion and decreased N-tubulin expressions are
indicated by white and black arrows, respectively.
(C) BCL6 MO or/and Notch1 MO was injected
into the left side of embryos, and left LPM tissues
were dissected from 20 embryos at stage 25 for
quantitative RT-PCR. *p < 0.01, n = 3; **p < 0.01,
n = 3; ***p < 0.01, n = 3.
(D) 1 ng ESR1-GR or Hairy2-GR was injected for
each experiment.
(E) 40 ng ESR1 MO or/and BCL6 MO was injected
for each experiment. The injected side is indicated
by ‘‘L’’ (left) beside the names of the injected
samples. L, left; R, right; a, anterior; p, posterior.
All error bars shown are standard deviation (SD)
from the mean of triplicates.
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Xenopus tropicalis ESR1 genomic locus was amplified by PCR
with primers designed with X. tropicalis genome sequences
(University of California Santa Cruz Genome Bioinformatics;
http://genome.ucsc.edu/) and linked to the luciferase reporter
(pGL3-ESR1P-2367). After this construct was coinjected with
NICD or/and BCL6/BCoR RNA into Xenopus embryos, the lucif-
erase activity was measured. Increased luciferase activity by
NICDwas decreased by the coinjection of BCL6 and BCoR, sug-
gesting that this fragment of the ESR1 gene includes the BCL6-
response element (Figure 6D; Figure S5A). A deletion analysis of
this genomic fragment revealed that the BCL6-response element
was present between 1072 and 740 (Figure 6D; Figure S5A);
however, consensus BCL6-binding sequences as published
previously (Chang et al., 1996) were not found between 1072
and 740. Electrophoretic mobility shift assays (EMSA) were
therefore performed with full-length or the C2H2-type zinc finger
domain of BCL6 recombinant protein (GST-BCL6 or GST-ZF) to
identify the BCL6-response element in this region of ESR1.
Several probes for EMSA were designed in the candidate region
of ESR1 (1072/740) and were radiolabeled by PCR. The
1030/897 probe resulted in a BCL6-retarded band (lane 3:
GST-BCL6; lane 4: GST-ZF in Figure 6E). Because BCL6 directly
interacts with this probe, we will refer to the corresponding
region of ESR1 as the BCL6-response element (see Figure 6D).
Indeed, the overexpression of the zinc finger domain of BCL6
(BCL6-ZF) could inhibit the expression of Pitx2, indicating that
BCL6-ZF competes with endogenous BCL6 for the BCL6-(E and F) Myc-tagged BCoR was expressed in embryos (E) without or (F) with th
Coimmunoprecipitation with a-Notch antibody was performed. a-vimentin antibo
(G) The expression of Pitx2 at stage 25 was tested by whole-mount in situ hybrid
tested embryo number are shown. Total numbers of each injection are shown as
Develobinding site and inhibits the function of BCL6 by displacing
endogenous BCL6 from the ESR1 locus (Figure 6F). Because
two nonoverlapping fragments (50 response element and 30
response element) of the BCL6-response element (Figure S5B)
could each interact with GST-ZF, there is likely more than one
BCL6-binding site in the BCL6-response element (Figure S5C).
These results indicate that direct binding of BCL6 to both the
target locus and the NICD is required for its ability to shut
down Notch target gene expression. These findings, in turn,
suggest a mechanism by which selective inhibition of specific
Notch-activated target genes is achieved.
DISCUSSION
We have uncovered that BCL6 recruits BCoR and blocks the
transcription of selected Notch target genes to maintain Pitx2
expression and LR asymmetry in Xenopus (Figure 7A). It should
be noted that mutations of human BCoR result in the Oculofacio-
cardiodental (OFCD) syndrome, which is characterized by
defective lateralization, including dextrocardia, asplenia, and
intestinal malrotation (Hilton et al., 2007; Ng et al., 2004). These
findings indicate that the dysfunction of BCL6 in mammals can
likely lead to defects of LR asymmetry. However, the defects
of LR asymmetry in BCL6-deficient mice have not been reported.
BCL6-deficient mice displayed defective GC development
and a selective defect in T cell-dependent antibody responses
(Ye et al., 1997), and also developed myocarditis and pulmonary
vasculitis (Dent et al., 1997; Ye et al., 1997; Yoshida et al., 1999).e BCL6 MO, and protein extracts were isolated from 50 embryos at stage 10.
dy was used for a mock immunoprecipitation.
ization, and the ratios of the Pitx2-expressing embryo number versus the total
‘‘n’’ on the top of each bar.
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Figure 6. The Mechanisms by Which BCL6 Shuts Down the Expression of Selected Notch Target Genes
(A) ChIP assays were performedwith nuclear extracts from stage-25 embryos by using a-BCL6 antibody, a-Notch1 antibody, or mouse IgG. Mouse IgGwas used
for a mock ChIP assay.
(B) 2 ng dn-Su(H) was injected into two-cell-stage embryos, and nuclear extracts were isolated at stage 10 for ChIP assays.
(C) BCL6MOor/and 1 ng Flag-MAM1was injected into two-cell-stage embryos, and nuclear extracts were isolated at stage 10 for ChIP assays. The levels of input
proteins were confirmed by immunoblotting.
(D) Deleted fragments of the X. tropicalis ESR1 gene were linked to the luciferase reporter. Numbers indicate the position of nucleotides from the initiation site.
(E) Incubation of GST-BCL6 or GST-ZF with a probe corresponding to a 134 bp (1030/897) element yielded one distinct retarded band indicated by an arrow.
(F) 2 ngBCL6 ZF-GR or/andmBCL6-GRwas injected for each experiment. The injected side is indicated by ‘‘L’’ (left) beside the names of the injected samples. L,
left; R, right; a, anterior; p, posterior.
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it remains possible that defects of LR asymmetry in BCL6-defi-
cient mice may have been overlooked because defects of LR
asymmetry are not lethal (Peeters and Devriendt, 2006). The
reexamination of BCL6-deficient mice will be required to
address this important question.
In mice, distinct asymmetric expression of Delta-like 1 (Dll1),
Notch1, and Notch2 around the node (Bettenhausen et al.,
1995; Krebs et al., 2003; Raya et al., 2003; Williams et al.,
1995) and asymmetric Notch activation have not been reported.
In Dll1 knockout or Notch1 and Notch2 double-knockout mice,
the symmetric expression of Nodal in the perinodal region is
completely abolished, and thesemice show defects of LR asym-
metry (Krebs et al., 2003; Raya et al., 2003). Similar to the studies
in mice, any LR asymmetry in the expression of Delta1, Serrate1,
and Notch1 around the Xenopus GRP was not observed458 Developmental Cell 18, 450–462, March 16, 2010 ª2010 Elsevier(Figure S2G), and the symmetric expression of Xnr1 on the
GRP was inhibited by the depletion of Xenopus Notch1 (Fig-
ure 2D; Figure S2I). These findings indicate that XenopusNotch1
initiates symmetric Xnr1 expression around the GRP required for
LR patterning, and these mechanisms are conserved between
mice and Xenopus. However, it still remains unclear whether
asymmetric Notch activity exists around the GRP. It is possible
that other signals, including the generation of a leftward fluid
flow in or close to the GRP by the rotation of cilia (Schweickert
et al., 2007), together could break the bilateral symmetry and
induce the left-specific Xnr1 expression in the LPM. In contrast,
studies in chick have shown that the expression of Dll1 around
the left side of Hensen’s node is stronger than the right, and
that asymmetric activity of Notch signaling on the left side of
the node regulates the left-side expression of Nodal (Raya
et al., 2004). It remains very likely that the precise role of NotchInc.
Figure 7. AModel for the Regulation of Notch Signaling by the BCL6/
BCoR Complex during LR Patterning
(A) At stage 25, the BCL6/BCoR complex inhibits Notch’s ability to suppress
Pitx2 expression initiated by Xnr1-dependent and -independent signals and
maintains LR asymmetry.
(B) Sequence-specific targeting of BCL6 to a subset of Notch-activated genes
occurs by an unknown mechanism. Once recruited, however, BCL6 both
competes MAM1 away from the locus and recruits BCoR, effectively blocking
Notch-dependent transcription.
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different among species.
We have shown that the expression of Pitx2 on the left LPM is
dually regulated in Nodal (Xnr1)-dependent and -independent
manners. The expression of Pitx2 in the absence of Nodal func-
tion has been reported in Notch1 and Notch2 knockout mice
(Krebs et al., 2003; Raya et al., 2003), mutations of mouse
PDK2 (Pennekamp et al., 2002), and FURIN-deficient mice (Con-
stam and Robertson, 2000). These findings suggest that Pitx2
expression is regulated in part by Nodal-independent mecha-
nisms. As we have found that Pitx2 expression is significantly
suppressed by loss of BCL6 or by the overexpression of NICD
or ESR1 in Xenopus embryos, this indicates that a Notch-ESR1
signal could simultaneously inhibit Nodal-dependent and -inde-
pendent signals to suppress the expression ofPitx2 (Figure S3A).
However, how the Notch-ESR1 signal inhibits these signals still
remains unknown. Interestingly, the Nodal-dependent expres-
sion of mouse Pitx2 is controlled by a two-step mechanism
during the patterning of LR asymmetry (Shiratori et al., 2001).
Nodal signal acting in cooperation with the transcription factor
FAST-1 is required to initiate left-side-specific expression of
mouse Pitx2; however, the relevant left-side-specific enhancer
is also dependent on Nkx2.5 to maintain activation. All of these
enhancer sequences are conserved at the Xenopus Pitx2 locus
(Shiratori et al., 2001), suggesting that the left-specific expres-
sion of Xenopus Pitx2 is regulated by the same two-step mech-
anism. ESR1may directly bind this left-side-specific enhancer of
Pitx2 and shut down Pitx2 expression, although an indirect inhi-
bition cannot be excluded. It will therefore be important to inves-
tigate in future studies which regulatory step of Pitx2 induction is
inhibited by the Notch-ESR1 cascade and how ESR1 inhibits
Pitx2 expression.
How does Notch signaling activate only the correct target
genes in the LPM? One may posit that distinct repressors
expressed in the LPM may play a crucial role in inhibiting the
transcription of unnecessary target genes during LPM develop-
ment, and that BCL6 must be such a factor. Indeed, our studiesDeveloshow that the expression of ESR1, but not Hairy2, was selec-
tively inhibited by BCL6, and that ESR1, but not Hairy2, inhibited
the expression ofPitx2 (Figure 5). BCL6 directly interacts with the
ESR1 cis-regulatory element (Figure 6) and competes with
MAM1 for the ANK domain of Notch1 to shut down the transcrip-
tion of ESR1 when Notch signaling is activated (Figure 7B).
Although 134 bp of the BCL6-response element at the ESR1
locus was identified, consensus BCL6-binding sequences
(Chang et al., 1996) were not found in this element (Figure 6D).
It is possible that BCL6 may interact with the ESR1 element
through slightly different binding sequences. Our study suggests
that there are multiple BCL6-binding sites in the BCL6-response
element of ESR1 (Figure S5C). Therefore, a further analysis of
this element remains necessary to identify the BCL6-binding
site(s) and address how BCL6 is recruited to the ESR1 locus.
Our data define an important mechanism by which BCL6 con-
strains Notch signaling to provide cell-type-appropriate outputs.
Because the expression of Notch1 overlaps with that of BCL6 in
diverse ectodermal and mesodermal tissues, including the eye,
the nervous system, and the somites (Figure S2A)—and, indeed,
both Notch signaling and BCL6 abnormalities have been impli-
cated in leukemias—this regulatory mechanism may be impor-
tant for other developmental, homeostatic, or pathophysiolog-
ical processes.
EXPERIMENTAL PROCEDURES
Embryo Manipulations
Eggs were artificially fertilized by using testis homogenate and cultivated in
0.13 Marc’s Modified Ringer’s solution (MMR) (Peng, 1991). Embryos were
staged according to Nieuwkoop and Faber (1967).
GST Pull-Down and Protein Identification by Mass Spectrometry
GST fusion proteins were produced in E. coli strain BL21. The bacterial cells
were disrupted by sonication in Phosphate Buffered Saline (PBS) with
protease inhibitor cocktail (EDTA-free Complete Mini, Roche Applied
Science). To purify the GST fusion proteins, glutathione-conjugated agarose
beads (Sigma) were added to those samples and incubated at 4C for 1 hr.
The beads were washed three times with 1% Triton-X in PBS buffer. For our
screen, GST fusion protein was additionally washed with lysate buffer
(20 mM Tris-HCl [pH 8.0], 5 mM MgCl2, 1 mM EDTA, 50 mM KCl, 0.1% Triton
X-100, 10% glycerol, and 1 mM dithiothreitol). Stage-15 to -25 embryos were
homogenized in lysate buffer containing protease inhibitors to isolate embry-
onic protein extracts. The beadswith GST or GST-ANK protein were incubated
with embryonic protein extracts at 4C for 4 hr. The samples were washed five
times with lysate buffer without glycerol. After the washes, the proteins asso-
ciated with GST or GST-ANK were eluted with elution buffer (200 mM Tris-HCl
[pH 8.0], 4 mMMgCl2, 0.8 mM EDTA, 40 mMKCl, 0.08% Triton X-100, 0.8 mM
dithiothreitol, 10 mM glutathione, and protease inhibitors) at 4C for 1 hr.
The eluted samples were separated by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE). The gel was stained with the Silver
Stain Plus kit (Bio-Rad). The candidate protein bands were excised from the
gel, digested with trypsin, and analyzed with matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The identi-
fication of candidate proteins was determined by the MASCOT search algo-
rithm (http://www.matrixscience.com). The monoisotopic peptide masses
were used to search the SwissProt database within a mass tolerance of
±0.2 Da for Xenopus laevis protein, and one missed cleavage was allowed.
Immunoprecipitation and Immunoblotting
Embryos were homogenized in lysate buffer, and embryonic protein extracts
were used for immunoprecipitation. The embryonic protein extracts were
incubated with an antibody at 4C overnight. a-Notch (Developmental
Studies Hybridoma Bank [DSHB]), a-BCL6 (R&D Systems, Inc.), a-RBP-Jkpmental Cell 18, 450–462, March 16, 2010 ª2010 Elsevier Inc. 459
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Biotechnology, Inc.), a-Myc (Santa Cruz Biotechnology, Inc.), and a-vimentin
(DSHB) antibodies were used for immunoprecipitation or immunoblotting.
All in vitro-translated proteins were synthesized by the TNT Coupled Reticulo-
cyte Lysate System (Promega) for immunoprecipitation studies.
Microinjection of Synthetic RNA and Morpholino Antisense Oligo
Capped synthetic mRNAs were generated by in vitro transcription with SP6
polymerase, using the mMessage mMachine kit (Ambion, Inc.). Morpholino
Antisense Oligos (MO) were designed and produced by Gene Tools, LLC.
For microinjections, embryos were transferred to 3% Ficoll 400 in 0.13
MMR, and injected embryos were cultured in 0.13 MMR until the desired
stage. In all injection studies, 100 pg GFP RNA for observing phenotypes or
250 pg nucb-gal RNA (red color) for whole-mount in situ hybridization was
injected for a tracer of injection. For the activation of GR-fused protein, dexa-
methasone (DEX: final concentration 10 mM)was added to themedium. Details
of plasmid construction and sequences of MOs are presented in the Supple-
mental Experimental Procedures.
b-Galactosidase Staining and Whole-Mount In Situ Hybridization
Embryos were fixed with gal fix solution (2% formaldehyde, 0.2% glutaralde-
hyde, 0.02% Triton-X, 0.01% sodium deoxycholate in PBS) on ice for 30 min.
Galactosidase activity was visualized with the RedGal substrate (Research
Organics) in staining buffer (5 mM K3[Fe(CN)6], 5 mM K4[Fe(CN)6], 2 mM
MgCl2 in PBS). After staining, embryos were refixed with MEMFA (0.1 M
MOPS, 2 mM EGTA [pH 8.0], 1 mM MgSO4, and 3.7% formaldehyde) for
30 min. Whole-mount in situ hybridization was performed essentially as
described previously (Harland, 1991; Takada et al., 2005) by using Digoxigenin
(Roche Applied Science)-labeled antisense RNA probes and BM purple
(Roche Applied Science) for the chromogenic reaction. Information on probes
is presented in the Supplemental Experimental Procedures.
RT-PCR Analysis
Total RNA was isolated by the method with 200 mg/ml Proteinase K described
previously (Hilz et al., 1975). Reverse transcriptase (RT) reaction for the
synthesis of cDNA was performed with Superscript II (Invitrogen) according
to the manufacturer’s instructions. Specimens were analyzed for gene expres-
sion levels using regular PCRwith TaqDNA polymerase (NewEngland Biolabs)
or the iQ5 Real-Time PCR Detection System (Bio-Rad) with the QuantiTect
SYBR Green PCR kit (QIAGEN). Information on primers is presented in the
Supplemental Experimental Procedures. All error bars shown are the standard
deviation (SD) from the mean of triplicates.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were performed with a kit from
Millipore (Kato et al., 2002; Sachs and Shi, 2000). Nuclei were isolated as
described previously (Almouzni et al., 1994). The isolated nuclei were resus-
pended in 360 ml nucleus isolation buffer (0.25 M sucrose, 10 mM Tris-HCl
[pH 7.5], 3 mM CaCl2, and protease inhibitor cocktail). Proteins were cross-
linked to DNA by adding formaldehyde (final concentration: 1%) and incubated
on ice for 10 min and at room temperature for 20 min. After centrifuging
samples, the nuclei were resuspended in 200 ml lysis buffer (1% SDS,
50 mM Tris-HCl [pH 8.1], 10 mM EDTA, protease inhibitor cocktail) on ice for
10 min. The lysate was sonicated ten times with 10 s pulses by using a sonica-
tor (Branson Sonifier 450, VWR) set to 50% of maximum power to reduce DNA
length to between 200 and 1,000 bp. After debris was removed, DNA was
quantified and adjusted to equal concentration for PCR. Information of primers
is presented in the Supplemental Experimental Procedures. One milliliter of
chromatin solution was used for each ChIP assay with a-BCL6, a-Notch1, or
a-Flag antibody. One percentage of chromatin solution was stored for the
input DNA.
Luciferase Reporter Assay
Luciferase reporter constructs of the ESR1 gene were generated by subclon-
ing different lengths of genomic fragments, between1 and2367, into pGL3
basic vector (Promega), and pRL-CMV (Promega) was used for the internal
control. Luciferase activity was measured by using the Dual Luciferase460 Developmental Cell 18, 450–462, March 16, 2010 ª2010 ElsevierReporter Assay System (Promega). All error bars shown are the SD from the
mean of triplicates. X. tropicalis genomic DNA was gifted by Dr. K. Tamai.
Electrophoretic Mobility Shift Assay
The electrophoretic mobility shift assay was performed as described (Huang
et al., 1995). Recombinant proteins, whichwere eluted from glutathione-conju-
gated agarose beads by prereaction buffer (50 mM Tris-HCl [pH 8.0], 50 mM
KCl, 1mMEDTA, 1mMEGTA, 5mMdithiothreitol, 20%glycerol, 10mMgluta-
thione, and protease inhibitors), were incubated for 10 min on ice in a 15 ml
reaction volume containing 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 7.5 mM
Mg2Cl, 1 mM EDTA, 1 mM EGTA, 5 mM dithiothreitol, 20% glycerol, 50 mg/ml
poly (dI-dC), and protease inhibitors. A 32P-labeled probe was added, and
incubation continued for 15 min on ice. The protein-DNA complex was sepa-
rated by electrophoresis through a 6% native polyacrylamide gel.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and are available with this article online at doi:10.1016/
j.devcel.2009.12.023.
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